Woodland Hill Center | |
400 Vision Drive, Asheboro, North Carolina 27203 | |
(336) 672-5450 | |
Name | Woodland Hill Center |
---|---|
Location | 400 Vision Drive, Asheboro, North Carolina |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 100 |
Occupancy Rate | 65.5% |
Medicare ID (CCN) | 345277 |
Legal Business Name | 400 Vision Drive Operations Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1467016105 |
Organization Name | 400 VISION DRIVE OPERATIONS LLC |
Address | 400 Vision Dr, Asheboro, NC 27203 |
Phone Number | 336-672-5450 |
News Archive
EcoNugenics® is proud to introduce BreastDefend™, a new nutraceutical compound formulated specifically to promote and maintain breast health. Physician-formulated BreastDefend is crafted from eight exclusive, clinically tested compounds, including scientifically supported nutrients, herbs, and medicinal mushrooms.
Primus Pharmaceuticals, Inc. has announced the issuance of a new composition of matter patent for Limbrel, the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis (OA). U.S. Patent #7,514,469 was recently issued by the U.S. Patent and Trademark Office.
Kids who receive antibiotics throughout the course of their childhoods gain weight significantly faster than those who do not, according to new Johns Hopkins Bloomberg School of Public Health research.
Researchers demonstrate both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of multiple sclerosis (MS), providing a potential new way to combat this debilitating disease.
› Verified 8 days ago
NPI Number | 1699728204 |
Organization Name | SUNBRIDGE REGENCY - NORTH CAROLINA, INC. |
Doing Business As | WOODLAND HILL CARE AND REHABILITATION CENTER |
Address | 400 Vision Dr, Asheboro, NC 27203 |
Phone Number | 336-672-5450 |
News Archive
EcoNugenics® is proud to introduce BreastDefend™, a new nutraceutical compound formulated specifically to promote and maintain breast health. Physician-formulated BreastDefend is crafted from eight exclusive, clinically tested compounds, including scientifically supported nutrients, herbs, and medicinal mushrooms.
Primus Pharmaceuticals, Inc. has announced the issuance of a new composition of matter patent for Limbrel, the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis (OA). U.S. Patent #7,514,469 was recently issued by the U.S. Patent and Trademark Office.
Kids who receive antibiotics throughout the course of their childhoods gain weight significantly faster than those who do not, according to new Johns Hopkins Bloomberg School of Public Health research.
Researchers demonstrate both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of multiple sclerosis (MS), providing a potential new way to combat this debilitating disease.
› Verified 8 days ago
NPI Number | 1912683095 |
Organization Name | ASHEBORO OPCO LLC |
Address | 400 Vision Dr, Asheboro, NC 27203 |
Phone Number | 908-506-4204 |
News Archive
EcoNugenics® is proud to introduce BreastDefend™, a new nutraceutical compound formulated specifically to promote and maintain breast health. Physician-formulated BreastDefend is crafted from eight exclusive, clinically tested compounds, including scientifically supported nutrients, herbs, and medicinal mushrooms.
Primus Pharmaceuticals, Inc. has announced the issuance of a new composition of matter patent for Limbrel, the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis (OA). U.S. Patent #7,514,469 was recently issued by the U.S. Patent and Trademark Office.
Kids who receive antibiotics throughout the course of their childhoods gain weight significantly faster than those who do not, according to new Johns Hopkins Bloomberg School of Public Health research.
Researchers demonstrate both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of multiple sclerosis (MS), providing a potential new way to combat this debilitating disease.
› Verified 8 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
EcoNugenics® is proud to introduce BreastDefend™, a new nutraceutical compound formulated specifically to promote and maintain breast health. Physician-formulated BreastDefend is crafted from eight exclusive, clinically tested compounds, including scientifically supported nutrients, herbs, and medicinal mushrooms.
Primus Pharmaceuticals, Inc. has announced the issuance of a new composition of matter patent for Limbrel, the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis (OA). U.S. Patent #7,514,469 was recently issued by the U.S. Patent and Trademark Office.
Kids who receive antibiotics throughout the course of their childhoods gain weight significantly faster than those who do not, according to new Johns Hopkins Bloomberg School of Public Health research.
Researchers demonstrate both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of multiple sclerosis (MS), providing a potential new way to combat this debilitating disease.
› Verified 8 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 2 |
Total Amount of Fines in Dollars | $98802 |
Number of Payment Denials | 0 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 32.89 | 14.46 |
Percentage of long-stay residents who lose too much weight | 10.26 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 24.62 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.74 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.22 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 1.14 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.55 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.07 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 25.1 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 91.03 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.7 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 59.33 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 31.62 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 5.64 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.69 | 95.98 |
Percentage of short-stay residents who made improvements in function | 56.7 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.13 | 82.93 |
News Archive
EcoNugenics® is proud to introduce BreastDefend™, a new nutraceutical compound formulated specifically to promote and maintain breast health. Physician-formulated BreastDefend is crafted from eight exclusive, clinically tested compounds, including scientifically supported nutrients, herbs, and medicinal mushrooms.
Primus Pharmaceuticals, Inc. has announced the issuance of a new composition of matter patent for Limbrel, the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis (OA). U.S. Patent #7,514,469 was recently issued by the U.S. Patent and Trademark Office.
Kids who receive antibiotics throughout the course of their childhoods gain weight significantly faster than those who do not, according to new Johns Hopkins Bloomberg School of Public Health research.
Researchers demonstrate both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of multiple sclerosis (MS), providing a potential new way to combat this debilitating disease.
› Verified 8 days ago
Clapp's Convalescent Nursing Home Inc Location: 500 Mountain Top Drive, Asheboro, North Carolina 27203 Phone: (336) 625-2074 | |
Alpine Health And Rehabilitation Of Asheboro Location: 230 East Presnell Street, Asheboro, North Carolina 27203 Phone: (336) 629-1447 | |